Institutional members access full text with Ovid®

Share this article on:

Pediatric Optic Neuritis: What Is New

Borchert, Mark MD; Liu, Grant T. MD; Pineles, Stacy MD; Waldman, Amy T. MD, MSCE

Journal of Neuro-Ophthalmology: September 2017 - Volume 37 - Issue - p S14–S22
doi: 10.1097/WNO.0000000000000551
Original Contribution

Abstract: Few diseases blur the margins between their childhood and adult-onset varieties as much as optic neuritis. This report will review our state of knowledge of pediatric optic neuritis, as well as its relationship to the latest consensus definitions of neuroinflammatory disease. Current diagnostic and treatment options will be explored, as well as our potential to uncover an understanding of pediatric optic neuritis through systematic prospective studies. The risk of evolving multiple sclerosis is probably less than in adults, but pediatric optic neuritis is more likely to be an initial manifestation of acute disseminated encephalomyelitis. Steroids may hasten visual recovery, but they do not change visual outcome except in cases because of neuromyelitis optica. The role of puberty in modifying the presentation and risk associations is unknown. Prospective studies are required to resolve these diagnostic and management issues.

The Vision Center (MB), Children's Hospital Los Angeles, Los Angeles, California; Departments of Ophthalmology and Neurology (MB), Keck School of Medicine, University of Southern California, Los Angeles, California; Neuro-ophthalmology Service (GTL), Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Departments of Neurology and Ophthalmology (GTL), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Department of Ophthalmology (SP), Stein Eye Institute, University of California, Los Angeles, California; Division of Neurology (ATW), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and Departments of Neurology and Pediatrics (ATW), Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Address correspondence to Mark Borchert, MD, Children's Hospital Los Angeles, MS#88, 4650 Sunset Boulevard, Los Angeles, CA 90027; E-mail: MBorchert@chla.usc.edu

The authors report no conflicts of interest.

© 2017 by North American Neuro-Ophthalmology Society